·ÅÉäÖÎÁÆ,radiotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼ªÎ÷Ëû±õ,gemcitabineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÇÐÎϸ°ûÁö,astrocytomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÅÉäÃô¸ÐÐÔ,RadiosensitivityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½ºÖÊÁö,gliomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖØÁ¿,WeightÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°û¶¾×÷ÓÃ,cytotoxicityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ë®ÌýÆ÷,hydrophoneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶òÂåÌæÄá,ErlotinibÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍÐÈðÃ×·Ò,ToremifeneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×ÁöÒÖËØ,tumstatinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ɱÉË»îÐÔ,Killing activityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÓÒÐýÄûÏ©,D-limoneneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ¹ÜÄÚÆ¤Éú³¤Òò×ÓÊÜÌå-3,vascular endothelial growth factor receptor-3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°û¶¾ÐÔ×÷ÓÃ,cytotoxicityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÂÈÈÁÆ·¨,thermotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
żÁªÎï,conjugateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃÀ·¨ÂØ,melphalanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×Áö/Á÷Ðв¡Ñ§,neoplasms/epidemiologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÒÍéÎøßø,EthaselenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶à¿Ë¡,PolyclonalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
188Re,~(188)ReÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫϸ°ûÉú³É,hematopoiesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µÍζ³´æ,cryopreservationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÈ×Ñ,ThermoseedÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
º£ÉúËØ,HaishengsuÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á¢ÌåÒì¹¹ÏÖÏó,StereoisomerismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½âÀëËØ,disintegrinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°©¿¹Ô125,CA125Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¥½¹µã,MonofocalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
18F-ÍÑÑõÆÏÌÑÌÇ,18F-FDGÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³ÉÁöÐÔ,tumorigenicityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ñõ»¯ßÅßáÑÜÉúÎï,oxindolesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µåÓñºì¼×ë¿,Indirubin-3'-monoximeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÝÆ,terpenoidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
È˶ËÁ£Ã¸´ß»¯ÑÇ»ù,hTERTÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹í±Ê»·ëÄ,phalloidinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²»ÈÜÐÔ¦Â-ÆÏ¾ÛÌÇ,CAIBGÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·øÉäÔöÃô,radiosensitizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
exosome,exosomesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼×Ì¥µ°°×(AFP),alpha-fetoprotein(AFP)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±íÑõ»¯Ã¸,epoxygenaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁܰÍÉú³É,lymphangiogenesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×Áö»µËÀÒò×ÓÏà¹ØÓÕµ¼µòÍöÅäÌå,TRAILÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢ÐÍË«¹¦ÄÜ¿¹Ìå,DiabodyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌåÄÚÉúÎï·Ö²¼,BiodistributionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃâÒß¼àÊÓ,immune surveillanceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ÔÍÌÊÉ,AutophagyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
˿״¼¡¶¯µ°°×,F-actinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼¤¹âɨÃèϸ°ûÒÇ,LSCÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹ã¶«/Á÷Ðв¡Ñ§,guangdong/epidemiologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈËÖ×Áö»µËÀÒò×Ó,hTNF¦ÁÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
aurora-A»ùÒò,aurora-AÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½ËÕ/Á÷Ðв¡Ñ§,Jiangsu/epidemiologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿ÅÁ£µ°°×ǰÌå,ProgranulinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹â»ÔÃ¹ËØ,mithramycinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ÏÌ´ËØ,pterocarpinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
1,2,4-±½Èý´¼,hydroxy-hydroquinonÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
188ïª,rhenium-188Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éß¶¾½â¾ÛËØ,ContortrostatinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
BCl3,BCl_3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÇÀë×Ó±íÃæ»îÐÔ¼ÁÅÝÄÒ,niosomeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿µÆÕÈð¶¡Á×Ëá¶þÄÆ,CA-4PÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
14-3-3¦Â»ùÒò,14-3-3¦ÂgeneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ά¼×ËáÄÍÒ©,ATRA-resistanceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏßÁ£ÌåÈÚºÏËØ»ùÒò-2,mitofusin-2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°û±íÃæÁ×ËữÌǵ°°×,CD_(34)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´ÅÏØ,CixianÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈËÀà±íƤÉú³¤Òò×ÓÊÜÌå,erbBsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éñ¾ÓªÑøÒò×Ó4,neurotrophinª²4Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»¥¸ô½»Á´æßÃ¹ËØ,AltenueneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
DNAÒÀÀµµ°°×¼¤Ã¸(DNA-PK),DNA-PKÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´×ËáÇúÆ×ÈðÁÖ,alarelinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
SIRP¦Á,SIRPaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Eca-9706ϸ°û,Eca-9706Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
TNFR·â±Õ»·ëÄ,TNF-BPÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºÚÉ«ËØÁö¿¹Ô-4,MAGE-4Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
pro-EMAP¢òµ°°×,pro-EMAP¢òproteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ELRÐòÁÐ,ELR-sequenceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼¯ºÏ»ùÒò,metageneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐØÏÙëĦÁ1(T¦Á1),Thymosin¦Á1(T¦Á1)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±í°¢Ã¹ËØ(EPI),Epirubicin(EPI)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ã×ÍÐÝìõ«(MIT),mitoxantone(MIT)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÆÍøµ°°×(CRT),calreticulin(CRT)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¬ÉùÃô¸Ð,ultrasonic-sensitiveÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
7,12-¶þ¼×»ù±½Ýì,7,12-DMBAÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÎëÄ,ACBP-LÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Æ¢ëÄ,ACBP-SÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»·(4-ôǸ¬-ÁÁ)¶þëÄ,cyclo-(4-hydroxy-Pro-Leu)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
RGD¶àëĽáºÏÐͰ¢¿ËÀÃ¹ËØA³¤Ñ»·Ö¬ÖÊÌå,RGD-ACM-A-LiposomeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎøËáõ¥¶àÌÇ(KSC),Kappa-selenocarrageenan(KSC)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×Áö/¶ñÐÔ,neoplasms/malignantÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃâÒß°ÐÏò,Immuno-targetingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
5-ÔÓµª-2'-ÍÑÑõ°ûà¤,5-aza-2'deoxycytidineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Gµ°°×Ðźŵ÷½Úµ°°×5(RGS5),RGS5Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Áܰ͹ÜÄÚÆ¤×æÏ¸°û,LEPCsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ò¶ËáżÁª,folate-conjugatedÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×ÁöѪ¹ÜÒÖÖÆëÄ,AlphastatinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ó¦¼¤/ÐÄÀíѧ,stress/psychologicalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÂÉúѪ¹Ü»¯/²¡ÀíÐÔ,neovascularization/pathologicÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|